Role of Sleep Apnea and Long-Term CPAP Treatment in the Prognosis of Patients With Melanoma
CHEST · 2023
DOI: 10.1016/j.chest.2023.06.012 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift CHEST, 2023. Verfasst von Jose Daniel Gómez-Olivas und 38 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Department, Hospital Universitario y Politecnico la Fe, Hospital de Manises, Valencia, Spain. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Melanoma, Skin Neoplasms, Sleep Apnea Syndromes. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: OSA has been associated with increased incidence and aggressiveness of melanoma. However, the long-term impact of OSA and CPAP treatment on the prognosis of melanoma remains unexplored. RESEARCH QUESTION: Are OSA and CPAP treatment associated independently with a poor prognosis for cutaneous melanoma? STUDY DESIGN AND METHODS: Four hundred forty-three patients with a diagnosis of cutaneous melanoma (2012-2015) underwent a sleep study within 6 months of diagnosis. The main 5-year outcome of the study was a composite of melanoma recurrence, metastasis, or mortality. Patients were divided into four groups: baseline apnea-hypopnea index (AHI) of fewer than 10 events/h (no OSA; control group), OSA treated with CPAP and good adherence, untreated or poor CPAP adherence in moderate (AHI, 10-29 events/h), and severe OSA (AHI, ≥ 30 events/h). Survival analysis was used to determine the independent role of OSA and CPAP treatment on melanoma composite outcome. RESULTS: Three hundred ninety-one patients (88.2%) were available for analysis at 5-year follow-up (mean age, 65.1 ± 15.2 years; 49% male; Breslow index, 1.7 ± 2.5 mm). One hundred thirty-nine patients had AHI of fewer than 10 events/h (control group); 78 patients with OSA were adherent to CPAP; and 124 and 50 patients had moderate and severe OSA, respectively, without CPAP treatment. Median follow-up was 60 months (interquartile range, 51-74 months). During follow-up, 32 relapses, 53 metastases, and 52 deaths occurred (116 patients showed at least one of the main composite outcomes). After adjusting for age, sex, sentinel lymph nodes affected at diagnosis, BMI, diabetes, nighttime with an oxygen saturation below 90%, Breslow index, Epworth sleepiness scale scores, and melanoma treatment, moderate (hazard ratio [HR], 2.45; 95% CI, 1.09-5.49) and severe OSA (HR, 2.96; 95% CI, 1.36-6.42) were associated with poorer prognosis of melanoma compared with the control group. However, good adherence to CPAP avoided this excess risk (HR, 1.66; 95% CI, 0.71-3.90). INTERPRETATION: Moderate to severe untreated OSA is an independent risk factor for poor prognosis of melanoma. Treatment with CPAP is associated with improved melanoma outcomes compared with untreated moderate to severe OSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Respiratory Department, Hospital Universitario y Politecnico la Fe, Hospital de Manises, Valencia, Spain.
- Respiratory Department, Instituto Andaluz de Investigación, Seville, Spain; Hospital Valme, IBIS, Instituto Andaluz de Investigación, Seville, Spain; CIBERes, VCIBER de Enfermedades Respiratorias, Madrid, Spain.
- Dermatology Department, Instituto Valenciano de Oncologia, Hospital de Manises, Valencia, Spain.
- Dermatology Department, Hospital de Manises, Valencia, Spain.
- Respiratory Department, Hospital Universitario La Paz, IdiPaz, Spain; CIBERes, VCIBER de Enfermedades Respiratorias, Madrid, Spain.
- Respiratory Department, Hospital General Universitario Balmis de Alicante, UMH, Spain; Clinical Medicine Department, UMH, Spain.
Zitieren
APA
Gómez-Olivas, J. D., Campos-Rodriguez, F., Nagore, E., Martorell, A., García-Rio, F., Cubillos, C., Hernandez, L., Bañuls, J., Arias, E., Ortiz, P., Cabriada, V., Gardeazabal, J., Montserrat, J. M., Carrera, C., Masa, J. F., Gomez de Terreros, J., Abad, J., Boada, A., Mediano, O., …, & Martinez-Garcia, M. A. (2023). Role of Sleep Apnea and Long-Term CPAP Treatment in the Prognosis of Patients With Melanoma. CHEST. https://doi.org/10.1016/j.chest.2023.06.012
Vancouver
Gómez-Olivas JD, Campos-Rodriguez F, Nagore E, Martorell A, García-Rio F, Cubillos C, et al. Role of Sleep Apnea and Long-Term CPAP Treatment in the Prognosis of Patients With Melanoma. CHEST. 2023. doi:10.1016/j.chest.2023.06.012
BibTeX
@article{GmezOlivas2023,
author = {Gómez-Olivas, Jose Daniel and Campos-Rodriguez, Francisco and Nagore, Eduardo and Martorell, Antonio and García-Rio, Francisco and Cubillos, Carolina and Hernandez, Luis and Bañuls, Jose and Arias, Eva and Ortiz, Pablo and Cabriada, Valentin and Gardeazabal, Juan and Montserrat, Josep Maria and Carrera, Cristina and Masa, Juan Fernando and Gomez de Terreros, Javier and Abad, Jorge and Boada, Adam and Mediano, Olga and Castillo-Garcia, Marta and Chiner, Eusebi and Landete, Pedro and Mayos, Mercedes and Fortuna, Ana and Barbé, Ferrán and Sanchez-de-la-Torre, Manuel and Cano-Pumarega, Irene and Perez-Gil, Amalia and Gomez-Garcia, Teresa and Cullen, Daniela and Somoza, Maria and Formigon, Manuel and Aizpuru, Felipe and Oscullo, Grace and Garcia-Ortega, Alberto and Almendros, Isaac and Farré, Ramón and Gozal, David and Martinez-Garcia, Miguel Angel},
title = {Role of Sleep Apnea and Long-Term CPAP Treatment in the Prognosis of Patients With Melanoma},
journal = {CHEST},
year = {2023},
doi = {10.1016/j.chest.2023.06.012}
}
EUVIMED